An independent analytical research newsletter that examines pharmaceutical open innovation, business development, M&A and corporate venture activity, using deal-level data and balance-sheet analysis. Recent issues dissect the external growth strategies of AstraZeneca, Eli Lilly and Novo Nordisk.

A Korean business development executive shares personal judgments and field experience on BD (business development) as seen from a CEO's perspective, using short essay-style issues. Readers get reasoned takes on how BD differs from sales and goal-tracking, and on how to evaluate and frame business decisions.

A South Florida business and creator economy newsletter covering practical opportunities for local owners, such as county vendor registration, SBA award deadlines, and arts grant timelines. Issues walk readers through eligibility, documents, and deadlines in a step-by-step, useful way.

A former research institute worker and biomedical MBA shares reflections on business development, drug development, and the tension between market logic and academic freedom. Each post pairs personal anecdotes with plain-language explanation of industry processes and mindset.